City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.
March 17, 2017 | Michael Easterling
Four City of Hope doctors have been named fellows by the American Society of Clinical Oncology (ASCO), an honor bestowed on fewer than 200 of the organization’s more than 40,000 members.
February 3, 2017 | Michael Easterling
As part of its Center for International Medicine (CIM) program, City of Hope recently hosted seven physicians from Renmin Hospital of Wuhan University, located the Hubei province of China.
December 1, 2016 | City of Hope
In this Q and A, Steven T. Rosen, M.D., provost and chief scientific officer for City of Hope, answers questions about the importance of precision of medicine in the fight against cancer and how the City of Hope and TGen alliance will advance research and treatment using this approach.
June 1, 2016 | Denise Heady
Members of City of Hope’s medical oncology team are part of a core group of medical professionals trying to find more ways to treat and eradicate cancer. At the 2016 ASCO meeting, they will share findings about a number of cancers and treatment approaches, including assessments of potential new therapies and comparisons of current therapies.
April 6, 2016 | City of Hope
City of Hope is launching a multifaceted five-year initiative aimed at reducing cancer risks through better nutrition, particularly for children, made possible with the help of a $2.5 million grant from the Conrad N. Hilton Foundation.
February 2, 2016 | Elise Lamar
Stat, Myc, Myb, Fos, Ras, and Fox: Those bland monosyllables, unfamiliar to most of us, command the respect and fear of oncologists and cancer researchers worldwide. Why? Because they name proteins that drive uncontrollable cell division, metastasis, and/or drug resistance in numerous cancers.